The continued involvement of civil society and scientific community is of high importance to the EU, as they play a crucial role in assessing and addressing the world drug situation. Civil society input provides added value to policy considerations, giving policy makers a view of a greater range of insights and information, gives a sense of legitimacy to policy actions, and directly contributes to national and EU drugs strategy objectives.
We are inviting you to learn about different experiences and good practices of civil society’s involvement in shaping, implementing drug policy and the benefits of this involvement!
Materials and presentations
Collaboration with civil society and governments in drug policies
Best practice: Lithuanian experience
Collaboration with civil society and governments in drug policies in the Czech Republic